The head of the federal Medicare and Medicaid agency said Wednesday in Atlanta that the new White House regulation on pharmaceutical TV ads will bring “much-needed pricing transparency to the market for prescription drugs.’’
The new policy, announced Wednesday, will require companies to disclose prices in TV ads for any drugs that will cost above $35 for a month’s supply or a usual course of therapy.
“Patients have the right to know the prices of health care services,’’ Seema Verma, administrator of the Centers for Medicare & Medicaid Services, told the National Rural Health Association’s annual conference. “At CMS, we are serious about empowering patients with pricing information across the board.’’
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
